Why FDA Approval Matters More Than You Think in Wellness Medicine

By Dr. Farhan Abdullah, DO | Medical Director, Magnolia Functional Wellness | Southlake, TX

A patient sat down across from me a few weeks ago, turned her phone around, and asked a question I hear almost every week. "Is this FDA-approved?" A friend had sent her a link. The product promised fat loss, deeper sleep, and more energy, and the landing page was full of very confident language.

She asked exactly the right question. What she didn't know was what the answer would actually tell her, or more importantly, what it wouldn't. That gap, between asking about FDA approval and understanding what approval certifies, is where a lot of smart people in wellness medicine get themselves into trouble.

I'm a board-certified internal medicine physician, and I still work shifts in a Dallas hospital. I also run Magnolia Functional Wellness here in Southlake. A surprising share of my week gets spent explaining regulatory status to people who walked in asking about something else entirely. It isn't the glamorous part of the job. It might be the most useful thing I do.

What FDA Approval Actually Certifies

Approval isn't a general blessing. It isn't a quality ribbon the agency hands out to products it likes. It's a narrow, specific finding: for one molecule, at defined doses, in a defined population, for a defined condition, a manufacturer submitted evidence that the benefits outweigh the risks, and the agency agreed.

Read that again and notice how much of it is bounded. Approval attaches to an indication, not to a substance floating free in the world. Ketamine is approved as an anesthetic. Botulinum toxin is approved for chronic migraine under a specific injection protocol. The molecule doesn't carry approval around with it into every possible use.

There's a second half of approval that almost nobody thinks about, and it's the half that quietly protects patients most days. Approval brings manufacturing under federal oversight. The facility gets inspected. Every batch has to meet standards for identity, purity, and potency. There's stability testing, so the product in the vial at month ten is still the product that was in it at month one. Labeling is regulated. And once the drug is on the market, the manufacturer is obligated to collect and report adverse events, while the agency retains authority to force a label change or pull the product entirely.

That machinery is invisible when it works. You notice it only by its absence.

Now the other side. Approval does not certify that a drug will work for you. It certifies that it worked, on average, in the people who were studied. It doesn't mean the drug is the best available option, and it says nothing about safety at doses or in populations that were never tested. I've had patients treat an approval letter as a personal guarantee. It isn't one.

How High the Evidence Bar Actually Sits

Most people underestimate what getting a drug approved requires, especially in metabolic medicine, where the trials have grown enormous.

Take the SELECT trial, published in the New England Journal of Medicine in 2023 by Lincoff and colleagues. Patients with preexisting cardiovascular disease who had overweight or obesity but not diabetes were randomized to weekly subcutaneous semaglutide at 2.4 mg or to placebo, then followed for years. The endpoint wasn't a number on a scale or a marker on a lab report. It was death from cardiovascular causes, nonfatal heart attack, and nonfatal stroke. Semaglutide beat placebo on that composite.

Or look at Jastreboff and colleagues in the same journal in 2022, the trial supporting tirzepatide once weekly for obesity. Again: randomized, placebo-controlled, large, long, and pre-registered, with the outcomes defined before a single patient enrolled.

A note on names, because this trips people up constantly. Ozempic and Wegovy are FDA-approved products. Semaglutide is the drug substance they're built on. Mounjaro and Zepbound are FDA-approved products built on tirzepatide. That distinction sounds pedantic right up until you realize how casually the words get swapped in marketing copy, and how much rides on which one is actually sitting in front of you.

Here's the part worth sitting with. Trials like these take years and cost hundreds of millions of dollars. A product that never ran one hasn't failed the test. It simply never took it. Those are two different situations, and neither one is the same as passing.

What Happens Where Approval Isn't Required

Dietary supplements in the United States don't go through premarket approval. A manufacturer doesn't have to demonstrate to the FDA that a product works, or even that it contains what the label claims, before putting it on a shelf. Enforcement is largely reactive. The agency moves after a problem surfaces.

We have a decent sense of what that system produces, because the FDA maintains a database of supplements found to be tainted with actual pharmaceutical drugs.

C. Michael White's 2022 analysis in the Journal of Clinical Pharmacology worked through that database across 2007 through 2021 and identified 1,068 unique products adulterated with active pharmaceutical ingredients. The two categories that dominated? Sexual enhancement and weight loss. Which happen to be precisely the categories that overlap with what people walk into a wellness clinic asking about.

An earlier look at the same problem, published by Tucker and colleagues in JAMA Network Open in 2018, examined FDA warnings tied to supplements containing unapproved pharmaceutical ingredients and found the pattern was already well entrenched years ago.

Sit with what that means for the person buying. These weren't products that merely failed to work. They contained undisclosed prescription drugs. A man taking nitrates for chest pain who swallows a "natural" enhancement capsule spiked with an undisclosed PDE5 inhibitor is in genuine danger, and nothing on that label would warn him.

Why This Matters More in Wellness Than It Does in the Hospital

I work in both worlds, and the contrast is stark enough that I think it explains most of the confusion.

When I admit a patient to the hospital, an enormous amount of regulatory scaffolding is already in place before I write a single order. There's a formulary, built by a pharmacy and therapeutics committee that argued about every item on it. There's a hospital pharmacist who reviews what I ordered and calls me when something looks wrong. There are interaction checks built into the ordering system. Nobody is marketing anything to the patient in that bed. The system is opinionated, and its opinions are mostly good ones.

Wellness medicine runs on almost none of that. Most of it is direct-pay, which means insurance isn't functioning as a second set of eyes, for better and for worse. There's no formulary committee. The patient frequently arrives having already done their own research, which in practice means they arrived having already been marketed to, repeatedly, by parties with something to sell. And the field moves fast enough that a treatment can go from obscure to ubiquitous in eighteen months without the evidence base moving at all.

None of that makes wellness medicine illegitimate. I built a clinic in it on purpose, because the conventional system does a poor job with patients who feel terrible and whose labs read as technically normal. But it does mean the guardrails you'd get for free in a hospital have to be rebuilt deliberately in a clinic. Regulatory literacy is one of those guardrails. When nobody else is screening what reaches you, knowing what approval does and doesn't mean becomes your own protection.

That's really why I keep coming back to this topic with patients who came in to talk about something else.

Off-Label Is Not the Same as Unapproved

This is the distinction I most often have to untangle, and the one most often blurred on purpose.

Off-label prescribing means a physician prescribes an FDA-approved product for a use outside its labeled indication. It's legal, it happens across every specialty in medicine, and in plenty of cases it rests on solid evidence that simply never went through the expense of a separate approval application. The key point: the product itself still cleared the entire process. Identity, purity, potency, manufacturing oversight, adverse event reporting, all intact. What sits outside the label is the use, not the drug.

Unapproved is a different animal. There, the molecule itself never cleared anything. No inspected facility standing behind it. No batch testing you can rely on. No mandatory adverse event reporting, and no recall authority if something goes wrong.

Bremelanotide makes a clean illustration. Vyleesi is the FDA-approved product. Material sold online as a research chemical under the same molecule name carries none of that structure, can't be legally prescribed, and offers you no way to verify what's actually in the vial. Same molecule on paper. Wildly different risk in practice.

When a clinic slides between those two categories in its advertising, notice it.

How I Use This in the Exam Room

Regulatory status isn't the end of a clinical conversation. It's the start of one. This is roughly how I work through it with patients at Magnolia.

First, I name the status plainly, out loud. Approved for this indication. Approved, but we'd be using it off-label. Not approved at all. Patients deserve that in words they can repeat to their spouse in the car on the way home.

Second, I ask what kind of evidence we're standing on. Are we looking at hard outcomes like heart attacks and deaths, or at surrogate markers that move on a lab report? Both have value. They are not the same thing, and marketing loves presenting the second as though it were the first.

Third, monitoring. If we're operating outside an approved indication, the bar for follow-up goes up, not down. Labs on a schedule. A clear, written list of what would make us stop. Actual visits, not a refill button.

If you're evaluating any wellness clinic, mine or the one advertising on a billboard off 114, a few questions are worth asking. What exactly is the product, by name? Is it FDA-approved, and for what indication? If we're going off-label, what evidence supports it? What will you monitor, how often, and what would make you stop? A clinic that answers those crisply is worth considering. A clinic that changes the subject has already told you something.

I have this conversation constantly on the peptide therapy side of the practice, where the distance between what's approved and what's marketed is probably the widest in all of wellness medicine. It comes up just as often when patients ask about our medical weight loss options in Southlake.

The Short Version

FDA approval isn't a magic word, and it isn't a marketing flourish. It's a package: an evidence standard tied to one specific use, plus ongoing manufacturing oversight, plus a safety reporting system with real teeth. Knowing which parts of that package apply to a treatment you're weighing tells you a great deal about the risk you're accepting.

It won't tell you whether something is right for you. That still takes a history, an exam, labs, and a physician willing to say "I don't know" when that's the honest answer. But it tells you what kind of ground you're standing on, and that isn't a small thing.

If you're anywhere around Southlake and you're weighing something you found online, bring it in. Bring the link, the screenshot, or the bottle if you already bought it. At Magnolia Functional Wellness we'll go through what it is, what's genuinely known about it, and whether it belongs anywhere near your plan. Sometimes the answer is yes. Sometimes it's a firm no. Either way, you'll leave understanding why.